3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
2
fludarabine
2
SS1(dsFv)PE38
2
Platinum
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cyclophosphamide
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
enzalutamide
1
entinostat
1
X-Rays
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Polymerase Chain Reaction
1
Paclitaxel
1
Nivolumab
1
Microarray Analysis
1
Megestrol Acetate
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
In Situ Hybridization, Fluorescence
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Referral and Consultation
×
Gynecologic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled